In Reply We appreciate the attention from Lim and colleagues to our Viewpoint1 on common myths in the use of levodopa in Parkinson disease (PD). We clarified in our article that the subtitle “When Clinical Trials Misinform Clinical Practice” should mean, if character counts had no limits, “when the interpretation of clinical trials misinform clinical practice.” We do not disagree on this point.